Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lydon

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Blood|November 14, 1997
The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cellsM W Deininger, J M Goldman, N Lydon, et al.
Journal De Pharmacie De Belgique|March 1, 1997
Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-RP Traxler, P Furet, H Mett, et al.
Journal of Medicinal Chemistry|June 7, 1996
4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinaseP M Traxler, P Furet, H Mett, et al.
Biochemical and Biophysical Research Communications|February 28, 1992
The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclaseS P Bottari, I N King, S Reichlin, et al.
Journal of Computer-Aided Molecular Design|December 1, 1995
Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411P Furet, G Caravatti, N Lydon, et al.
Experimental Cell Research|October 1, 1988
Electroporation of cultured adult rat hepatocytes with the c-myc gene potentiates DNA synthesis in response to epidermal growth factorS F Muakkassah-Kelly, D A Jans, N Lydon, et al.
Journal of Medicinal Chemistry|June 23, 1995
[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinaseP Traxler, U Trinks, E Buchdunger, et al.
International Journal of Cancer|May 21, 1999
Author errataN Lydon, H Mett, M Mueller, et al.
Journal of Medicinal Chemistry|April 1, 1994
Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinaseU Trinks, E Buchdunger, P Furet, et al.
Journal of Medicinal Chemistry|November 14, 1997
Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidinesP Traxler, G Bold, J Frei, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Blood|November 14, 1997
The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cellsM W Deininger, J M Goldman, N Lydon, et al.
Journal De Pharmacie De Belgique|March 1, 1997
Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-RP Traxler, P Furet, H Mett, et al.
Journal of Medicinal Chemistry|June 7, 1996
4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinaseP M Traxler, P Furet, H Mett, et al.
Biochemical and Biophysical Research Communications|February 28, 1992
The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclaseS P Bottari, I N King, S Reichlin, et al.
Journal of Computer-Aided Molecular Design|December 1, 1995
Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411P Furet, G Caravatti, N Lydon, et al.
Experimental Cell Research|October 1, 1988
Electroporation of cultured adult rat hepatocytes with the c-myc gene potentiates DNA synthesis in response to epidermal growth factorS F Muakkassah-Kelly, D A Jans, N Lydon, et al.
Journal of Medicinal Chemistry|June 23, 1995
[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinaseP Traxler, U Trinks, E Buchdunger, et al.
International Journal of Cancer|May 21, 1999
Author errataN Lydon, H Mett, M Mueller, et al.
Journal of Medicinal Chemistry|April 1, 1994
Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinaseU Trinks, E Buchdunger, P Furet, et al.
Journal of Medicinal Chemistry|November 14, 1997
Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidinesP Traxler, G Bold, J Frei, et al.
Pageof 2